Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.53 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.42 |
| ▸ | BID | P55957 | 3/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.42 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.42 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.42 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | EP300 | Q09472 | 1/20 | 0.42 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.42 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.42 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.42 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.42 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16895142 | 0.98 | LIPG (0.54) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822174 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822090 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822091 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822098 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Potassium Ion SCHEMBL23749193 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822088 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822101 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Potassium Ion SCHEMBL21822103 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID | |
| Lithium Ion SCHEMBL21822093 | 0.97 | LIPG (0.53) | LIPGNR1H2NR1H3KCNH2BID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112125807-B | Method for synthesizing n-octylamine by using loop reactor | 重庆合汇制药有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-112125807-A | Method for synthesizing n-octylamine by using loop reactor | 重庆合汇制药有限公司 | 2020-12-25 | — | — | CN | disclosed |
| US-9394221-B2 | Method for manufacturing benzenetetracarboxylic acid | JX NIPPON OIL & ENERGY COMPANY (JP) | 2016-07-19 | — | — | US | disclosed |
| US-20140018569-A1 | METHOD FOR MANUFACTURING BENZENETETRACARBOXYLIC ACID | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-01-16 | — | — | US | disclosed |
| JP-2000260493-A | SOLAR CELL | TAYCA CORP | 2000-09-22 | — | — | JP | disclosed |
| US-5149756-A | HYBRID AMINO RESIN COMPOSITIONS | MONSANTO COMPANY (US) | 1992-09-22 | — | — | US | disclosed |
| US-5087690-A | Curable blend of an alkoxymethyl amino resin, hydroxy coreactant, a (meth)acryloyl, an allylic or vinylbenzyl component and a metal sulfonate catalyst; high solids; compatability; gloss hardness; adhesives; coatings | MONSANTO (US) | 1992-02-11 | — | — | US | disclosed |
| EP-0381657-A2 | Hybrid amino resin compositions | MONSANTO COMPANY (US) | 1990-08-08 | — | — | EP | disclosed |
| EP-0380466-A2 | Hybrid amino resin compositions | MONSANTO COMPANY (US) | 1990-08-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140018569-A1 | METHOD FOR MANUFACTURING BENZENETETRACARBOXYLIC ACID | HAAO, HAO2, HPD | LIPG 2687/4885NR1H2 1122/4885NR1H3 962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.